Form 4: Alset International and Alset Inc. Sell Shares of Impact Biomedical Inc.

Alset International and Alset Inc., entities related to director Chan Heng Fai Ambrose, sold shares of Impact Biomedical Inc. on March 31 and April 1, 2025.

Summary

• This Form 4 filing reports the sale of Impact Biomedical Inc. (IBO) shares by Alset International Limited and Alset Inc.
• The transactions occurred on March 31, 2025, and April 1, 2025.
• Alset International Limited sold 300,000 shares on March 31, 2025, at a weighted average price of $1.028 per share.
• On April 1, 2025, Alset International Limited sold an additional 400,000 shares at a weighted average price of $0.9816 per share.
• Alset Inc. sold 650,000 shares on April 1, 2025, at a weighted average price of $1.447 per share.
• Alset Inc. also sold 1,176,918 shares on April 1, 2025, at a weighted average price of $1.08 per share.
• Chan Heng Fai Ambrose, a director and 10% owner of Impact Biomedical, may be deemed the beneficial owner of shares held by Alset Inc. and Alset International Limited.
• Following these transactions, Mr. Chan may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through various entities.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the sale of shares by entities related to a director, which can be interpreted as a lack of confidence in the company's future performance.

Negatives

• Entities related to a director and 10% owner are selling shares, which could be perceived negatively by the market.

Risks

• Continued selling pressure from related parties could negatively impact the stock price.
• The reasons for the share sales are not disclosed, creating uncertainty for investors.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Related Party Transactions

• The share sales by Alset International Limited and Alset Inc. are considered related-party transactions due to their relationship with director Chan Heng Fai Ambrose.

Stakeholder Impact

• Shareholders may react negatively to the news of share sales by related parties.
• The stock price could be negatively impacted by the increased selling pressure.

Key Dates

Keywords

Impact Biomedical Inc., Alset International Ltd, Alset Inc., Chan Heng Fai Ambrose, share sale, Form 4, beneficial ownership